Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-23-016164
Filing Date
2023-05-18
Accepted
2023-05-18 16:43:55
Documents
1
Period of Report
2023-05-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 5386
  Complete submission text file 0001127602-23-016164.txt   6768
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Issuer) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYTOKINETICS, INCORPORATED 350 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
Harrington Robert Arthur (Reporting) CIK: 0001923988 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50633 | Film No.: 23936749